JSF Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
10,083
+432
+4% +$56.9K 0.2% 69
2026
Q1
$1.35M Sell
9,651
-513
-5% -$71.8K 0.26% 49
2025
Q4
$1.25M Buy
+10,164
New +$1.24M 0.26% 52

Other funds holding GILD

JSF Financial's GILD Position: Q2 2026 in Review

JSF Financial increased its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, buying an estimated $56.9K and bringing the position to 10,083 shares worth $1.27M. The position accounts for 0.2% of the portfolio, ranked #69.

JSF Financial first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.35M in Q1 2026. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • JSF Financial held 10,083 shares of Gilead Sciences worth $1.27M as of Q2 2026.
  • JSF Financial bought 432 Gilead Sciences shares in Q2 2026, an estimated $56.9K.
  • Gilead Sciences made up 0.2% of JSF Financial's portfolio in Q2 2026, its #69 holding.
  • JSF Financial first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • JSF Financial's Gilead Sciences position peaked at $1.35M in Q1 2026.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on JSF Financial's 13F filing for Q2 2026, filed 28 Jul 2026.